• MEG3, NiO Nanoparticles, and Pulmonary Fibrosis

  2026-09-18

  Zhan et al. identify lncRNA MEG3 as a regulatory brake on nickel oxide nanoparticle-induced pulmonary fibrosis, linking MEG3 loss to TGF-β1 activation and PI3K/AKT-dependent collagen formation. By combining a rat exposure model, A549 cell experiments, pharmacologic inhibition, and MEG3 overexpression, the study provides a mechanistic framework for investigating toxicant-driven fibrotic remodeling.

• GS967 and Late INa in Cardiac Aging

  2026-09-18

  GS967 is a cardiac late sodium current inhibitor for dissecting how pathological Na+ influx links electrical instability with impaired relaxation. This article translates Nav1.5 Ser571 aging research into practical assay decisions for electrophysiology, calcium handling, and arrhythmia prevention research.

• Ceruletide Workflows for Pancreatic Fibrosis

  2026-09-17

  Ceruletide, also called Caerulein, provides a controllable CCK-receptor stimulus for pancreatic injury, secretion, fibrosis, and gastrointestinal motility experiments. This practical workflow connects reagent handling with MFGE8–ANXA1–SMAD2/3 research while emphasizing assay controls, formulation stability, and translational limits.

• Sisomicin Activity Against Clinical Isolates: 1975 Evidence

  2026-09-17

  Stewart and Bodey evaluated sisomicin against a broad panel of clinical isolates and compared its in vitro activity with gentamicin, tobramycin, amikacin, butirosin, and kanamycin. The study’s main contribution was to define sisomicin’s strong activity against many Gram-negative bacilli while showing that cross-resistance with gentamicin and tobramycin remained an important limitation.

• Proteinase K for DNA Integrity and Protein Hydrolysis

  2026-09-16

  Proteinase K is a broad-spectrum serine protease used for protein hydrolysis in molecular biology and enzyme contaminant removal for DNA prep. The K1037 formulation combines broad substrate specificity with resistance to EDTA and detergents, supporting genomic DNA isolation while preserving DNA integrity when the workflow is properly controlled.

• Metoprolol Tartrate for β1-Selective Research

  2026-09-16

  Metoprolol Tartrate enables selective β1-adrenergic receptor inhibition for cardiac signaling, hypertension research, and carefully controlled hematopoietic studies. Its contrast with nonselective β-blockade helps researchers separate cardiac receptor effects from broader adrenergic biology.

• Nav1.5 Ser571, Late INa, and the Aging Heart

  2026-09-15

  The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic relaxation during cardiac aging. By combining age comparisons with phosphomimetic and phosphoablated mouse models, cardiac measurements, and myocyte mechanics, the work shows how late INa can connect electrical and mechanical dysfunction.

• Rotigotine Hydrochloride: From Assay to Translation

  2026-09-15

  Rotigotine hydrochloride offers translational researchers a rare combination of broad dopaminergic pharmacology, non-dopaminergic receptor activity, and clinically relevant continuous-delivery precedent. This thought-leadership guide connects receptor biology, model selection, analytical control, and exposure strategy to help teams design more reproducible Parkinson’s disease and neurodegeneration studies.

• Rotigotine and Bladder Control in Parkinson’s Rats

  2026-09-14

  The reference study connects rotigotine pharmacology with lower urinary tract dysfunction in a 6-hydroxydopamine rat model, showing that administration route and timing produce different cystometric outcomes. Its findings support careful evaluation of dopaminergic therapies for bladder overactivity rather than assuming that motor benefits predict autonomic effects.

• Pexidartinib (PLX3397) Assay Guide

  2026-09-14

  A scenario-based guide to using Pexidartinib (PLX3397), SKU B5854, in cell viability, proliferation, and cytotoxicity workflows. It explains dose design, DMSO handling, assay interpretation, macrophage biology, and practical criteria for selecting a reliable research reagent.

• Tianhuang Formula, Berberine, and RAGE/POMC

  2026-09-13

  A 2026 pre-proof study identifies RAGE/POMC signaling as a central mechanism through which berberine may protect hypothalamic neurons and improve glucolipid metabolism. Its integrated computational, cellular, and mouse-model design links neuronal apoptosis and autophagy with metabolic outcomes, while leaving causal validation and relevance to neurodegenerative disease open.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-09-12

  Zhou et al. identified TSPAN18 as a regulator of STIM1 stability that protects STIM1 from TRIM32-mediated ubiquitination and degradation. The resulting increase in STIM1-dependent calcium entry promotes prostate cancer migration, invasion, and bone metastasis, providing a mechanistic link between protein turnover and metastatic signaling.

• Mdivi-1 Workflow for DRP1 and Apoptosis Studies

  2026-09-11

  Build a practical Mdivi-1 workflow that connects mitochondrial fission, apoptosis, and endothelial–smooth muscle cell crosstalk. The guide translates recent hypoxia pulmonary hypertension findings into controlled assays, troubleshooting decisions, and comparison-ready readouts.

• Ertugliflozin Cardiovascular Outcomes in Type 2 Diabetes

  2026-09-11

  The VERTIS CV trial evaluated long-term cardiovascular safety of ertugliflozin in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Its main contribution was demonstrating noninferiority for major adverse cardiovascular events, while the directionally favorable heart-failure and renal findings did not establish statistical superiority.

• Sulfo-NHS-SS-Biotin for Cell-Surface Workflows

  2026-09-10

  Sulfo-NHS-SS-Biotin combines water-compatible amine labeling with a cleavable disulfide linker, making it useful for cell-surface proteomics, reversible affinity capture, and antibody workflows. This guide translates emerging glycoRNA–RNA-binding-protein biology into practical labeling, enrichment, validation, and troubleshooting decisions.

8017 records 1/535 page Next 12345 下5页 Last page